12-05-2025
Clinicians Invited To Explore Breakthroughs In Psychedelics At PS2025
Rick Doblin, Ph.D., founder and president of the Multidisciplinary Association for Psychedelic ... More Studies (MAPS) at PS2023.
Psychedelic Science 2025 (PS2025) is inviting trauma therapists and other mental health professionals to attend its upcoming conference, which is designed for licensed clinicians. The event aims to inform attendees about psychedelic-assisted therapy modalities and other therapeutic tools, offering opportunities to engage with the latest research from leading experts in the field.
Organizers believe these fundamental tools can arm health professionals with an expanded therapeutic toolkit to address mental health conditions. PS2025 will be hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), taking place on June 16–20. It will return this year at the Colorado Convention Center in Denver.
Keynote speakers—educating about recent breakthroughs in psychedelics—include New York Times bestseller Bessel van der Kolk, former U.S. senator Kyrsten Sinema, author Paul Stamets, Oprah Daily Editorial Director Pilar Guzmán, MAPS Founder Rick Doblin, neuroscientist Robin Carhart-Harris, and former congressman Tim Ryan.
The event's Therapy Track programming was created specifically for licensed clinicians. It will feature select CE/CME-accredited workshops on psychedelic-assisted therapy modalities, ethics, and integration. There will also be data-driven sessions based on peer-reviewed research and clinical application, culturally responsive programming and diverse practitioner voices, and opportunities to connect with global experts in trauma-informed psychedelic care.
Joseph McCowan, Psy.D., a member of the Lykos Board of Directors and chair of the PS2025 Therapy ... More Curatorial Committee
Joseph McCowan, Psy.D., a member of the Lykos Board of Directors and chair of the PS2025 Therapy Curatorial Committee, emphasized the importance of meeting with clinicians, regardless of their experience with psychedelics.
'The Therapy Track at PS2025 is designed to meet clinicians where they are. Whether they're just beginning to explore psychedelic-assisted therapy or already immersed in the work, our goal is to equip mental health professionals with the tools, training, and connections they need to safely and effectively incorporate psychedelic-assisted therapy into their practice,' McCowan wrote in an exclusive statement.
'With CE-accredited workshops, real-world clinical case studies, and sessions that span ethics, integration, and emerging modalities, this year's conference is a unique opportunity for clinicians to engage with the science—and shape the future—of psychedelic care,' McCowan said.
The event's Therapist Track includes the following handful of sessions:
A full list of speakers and workshops were announced, providing evidence-based, trauma-informed practices. Workshops and sessions will be led by industry-leading researchers, therapists, and clinicians.
Among many other topics, leading researchers hope to dispel myths about substances such as MDMA. PS2025 will also feature workshops, some of which will provide CE/CME credits:
Former secretary of energy and former Texas governor Rick Perry speaks at PS2023.
On May 8, PS2025's expanded Business Track was announced. 'Psychedelic Science 2025 is where science, business, and policy converge to shape the next leap forward,' Amy Emerson, founder & former CEO of Lykos Therapeutics, said in the announcement. 'The psychedelic industry is entering a critical phase of maturation—one that demands not just resilience, but collaboration, standardization, and strategic investment. To translate groundbreaking research into safe, effective, and accessible treatments, we must build an ecosystem that unites researchers, regulators, clinicians, and policymakers. Psychedelic medicine isn't just an investment opportunity—it's a collective movement to transform mental health care. Now is the time for bold, cross-disciplinary action to build a sustainable future where psychedelic therapies are not just innovative, but scalable, trusted, and transformative.'
As psychedelic-assisted therapies become closer on the horizon, PS2025 aims to prepare mental health professionals for what's next. Additional speakers and conference sessions will continue to be announced in the weeks leading up to the conference.
